BCL2 and Parkinson disease: Recently it has been reported that EPO reduces neurodegeneration in a 6-OHDA mouse model of PD by inducing the expression of anti-apoptotic (Bcl-2) and anti-oxidant (glutathione peroxidase) factors within the striatum [68].